Throughout this medical market research, the publisher analyzed 20 dental bone graft substitutes companies in Mexico and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.
While this MedSuite report contains all of the Mexican Dental Bone Graft Substitutes Market analysis, each of the market segments is also available for purchase as a stand-alone report, MedCore.
Markets Covered
Mexican Dental Bone Graft Substitutes Market Insights
Overall, the Mexico dental bone graft substitute and other biomaterials market was valued at $8.5 million in 2020. This is expected to increase over the forecast period at a CAGR of 15.9% to reach $23.8 million in 2027.
An ongoing trend in Mexico is the continued presence of off-label sales. Offered by what has been described as copy-cat brands, these bone grafts are labeled as generic or bioequivalent to premium products. By promising to deliver premium quality at a much lower price, off-label products are able to attract a large customer base.
Straumann was the leading competitor in the total dental bone graft substitute market. In the past, Straumann’s involvement in the regenerative market was mainly limited to sales of its synthetic product BoneCeramic™. In 2018, Straumann expanded its partnership with botiss biomaterials by acquiring 30% of the company. As a result, Straumann extended its product catalog with new bone graft substitutes, such as cerabone® and maxgraft®.
While this MedSuite report contains all of the Mexican Dental Bone Graft Substitutes Market analysis, each of the market segments is also available for purchase as a stand-alone report, MedCore.
Markets Covered
- Dental Bone Graft Substitutes Market - MedCore
- Dental Barrier Membranes Market - MedCore
- Dental Growth Factor Market - MedCore
Mexican Dental Bone Graft Substitutes Market Insights
Overall, the Mexico dental bone graft substitute and other biomaterials market was valued at $8.5 million in 2020. This is expected to increase over the forecast period at a CAGR of 15.9% to reach $23.8 million in 2027.
An ongoing trend in Mexico is the continued presence of off-label sales. Offered by what has been described as copy-cat brands, these bone grafts are labeled as generic or bioequivalent to premium products. By promising to deliver premium quality at a much lower price, off-label products are able to attract a large customer base.
Straumann was the leading competitor in the total dental bone graft substitute market. In the past, Straumann’s involvement in the regenerative market was mainly limited to sales of its synthetic product BoneCeramic™. In 2018, Straumann expanded its partnership with botiss biomaterials by acquiring 30% of the company. As a result, Straumann extended its product catalog with new bone graft substitutes, such as cerabone® and maxgraft®.
Table of Contents
Table of ContentsList of FiguresList of ChartsExecutive SummaryMexico Dental Bone Graft Substitute and Other Biomaterials Market OverviewCompetitive AnalysisMarket TrendsMarket DevelopmentsMarkets IncludedKey Report UpdatesVersion HistoryAbbreviations
Research Methodology
Impact of COVID-19 on the Mexico Dental Bone Graft Substitute and Other Biomaterials Market
Disease Overview
Product Assessment
Mexico Dental Bone Graft Substitute and Other Biomaterials Market Overview
Procedure Numbers
Dental Bone Graft Substitute Market
Dental Barrier Membrane Market
Appendix: Dental Growth Factor Market
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AB Dental
- ACE Surgical
- B&W
- Bicon
- BioHorizons
- Bionnovation
- Bios Light
- Bioteck
- Dentsply Sirona
- Envista
- Geistlich
- Keystone Dental
- KOKEN
- Matcom
- Medica-Integra
- Megagen
- Osteogenics
- Straumann Group
- Tirden
- Zimmer Biomet
